kourosh Lotfi

About kourosh Lotfi

kourosh Lotfi, With an exceptional h-index of 22 and a recent h-index of 15 (since 2020), a distinguished researcher at Linköpings Universitet,

His recent articles reflect a diverse array of research interests and contributions to the field:

Integrated drug profiling and CRISPR screening identify BCR:: ABL1-independent vulnerabilities in chronic myeloid leukemia

First-line venetoclax combinations in chronic lymphocytic leukemia

IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors

Integrated High-Throughput Drug Profiling and CRISPR Screening Identify Novel Pathway Vulnerabilities of Leukemic Stem Cells in Chronic Myeloid Leukemia

Early changes in gene expression profiles in AML patients during induction chemotherapy

Multiplexed single‐cell mass cytometry reveals distinct inhibitory effects on intracellular phosphoproteins by midostaurin in combination with chemotherapy in AML cells

A randomized phase III study of venetoclax-based time-limited combination treatments (RVe, GVe, GIVe) vs standard chemoimmunotherapy (CIT: FCR/BR) in frontline chronic …

Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells

kourosh Lotfi Information

University

Position

Associate professor

Citations(all)

2286

Citations(since 2020)

1375

Cited By

1454

hIndex(all)

22

hIndex(since 2020)

15

i10Index(all)

40

i10Index(since 2020)

23

Email

University Profile Page

Google Scholar

Top articles of kourosh Lotfi

Integrated drug profiling and CRISPR screening identify BCR:: ABL1-independent vulnerabilities in chronic myeloid leukemia

Blood, The Journal of the American Society of Hematology

2020/2/27

First-line venetoclax combinations in chronic lymphocytic leukemia

New England Journal of Medicine

2023/5/11

IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors

Oncoimmunology

2022/12/31

Integrated High-Throughput Drug Profiling and CRISPR Screening Identify Novel Pathway Vulnerabilities of Leukemic Stem Cells in Chronic Myeloid Leukemia

Blood

2022/11/15

Early changes in gene expression profiles in AML patients during induction chemotherapy

BMC genomics

2022/11/14

Kourosh Lotfi
Kourosh Lotfi

H-Index: 14

Multiplexed single‐cell mass cytometry reveals distinct inhibitory effects on intracellular phosphoproteins by midostaurin in combination with chemotherapy in AML cells

Experimental hematology & oncology

2021/12

Thomas Gustafsson
Thomas Gustafsson

H-Index: 36

Kourosh Lotfi
Kourosh Lotfi

H-Index: 14

A randomized phase III study of venetoclax-based time-limited combination treatments (RVe, GVe, GIVe) vs standard chemoimmunotherapy (CIT: FCR/BR) in frontline chronic …

Blood

2021/11/23

Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells

Cell Death & Disease

2021/9/25

Sensitivity of acute myelocytic leukemia cells to the dienone compound VLX1570 is associated with inhibition of the ubiquitin-proteasome system

Biomolecules

2021/9/10

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI

Leukemia

2021/8

Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study

Bone Marrow Transplantation

2021/4

Single-cell RNA sequencing of hematopoietic stem and progenitor cells treated with gemcitabine and carboplatin

Genes

2020/5/14

Kourosh Lotfi
Kourosh Lotfi

H-Index: 14

Varying effects of tyrosine kinase inhibitors on platelet function—A need for individualized CML treatment to minimize the risk for hemostatic and thrombotic complications?

Cancer medicine

2020/1

Kourosh Lotfi
Kourosh Lotfi

H-Index: 14

See List of Professors in kourosh Lotfi University(Linköpings Universitet)